3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Thoracic
1
Other solid neoplasm
1
Gynecologic
1
Gastrointestinal
1
Conditions
Lung Neoplasms
5
Prostatic Neoplasms
2
Breast Neoplasms
2
Stomach Neoplasms
1
Sarcoma
1
Pseudomyxoma Peritonei
1
Paranasal Sinus Neoplasms
1
Ovarian Neoplasms
1
Oropharyngeal Neoplasms
1
Mouth Neoplasms
1
Mesothelioma, Malignant
1
Maxillary Sinus Neoplasms
1
Lymphoma
1
Laryngeal Neoplasms
1
Kidney Neoplasms
1
Hypopharyngeal Neoplasms
1
Head and Neck Neoplasms
1
Fasting
1
Esophageal Neoplasms
1
Disease
1
Colorectal Neoplasms
1
Colonic Neoplasms
1
Cigarette Smoking-Related Carcinoma
1
Carcinoma, Ovarian Epithelial
1
Carcinoma, Non-Small-Cell Lung
1
Appendiceal Neoplasms
1
Interventions
Paclitaxel
12
pembrolizumab
7
Carboplatin
7
Cisplatin
6
Docetaxel
5
sargramostim
4
Taxes
4
Cyclophosphamide
4
Amifostine
4
Trastuzumab
3
Polymerase Chain Reaction
3
Nivolumab
3
Irinotecan
3
Gemcitabine
3
Etoposide
3
talazoparib
2
aldesleukin
2
Vorinostat
2
Vinorelbine
2
SS1(dsFv)PE38
2
Pemetrexed
2
Interleukin-12 Subunit p35
2
Interleukin-12
2
Immunoenzyme Techniques
2
Gene Expression Profiling
2
Flow Cytometry
2
Filgrastim
2
Erlotinib Hydrochloride
2
tocilizumab
1
tislelizumab
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Carcinoma, Ovarian Epithelial
×
Referral and Consultation
×
Thoracic
×
Clear all
NCT01126346
2018-07-03
HOPE
Wake Forest University Health Sciences
Phase NA
Completed
10 enrolled